search
Back to results

Enteral Resuscitation Nepal (Pilot Study)

Primary Purpose

Burn Body Region Unspecified, Burn Shock

Status
Completed
Phase
Phase 3
Locations
Nepal
Study Type
Interventional
Intervention
Oral Rehydration Solution
Lactated Ringer
Sponsored by
University of Washington
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Burn Body Region Unspecified focused on measuring Burns, Enteral Resuscitation, Oral Rehydration Solution, Burn Shock, Austere Conditions, Low- and middle-income country

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • All genders
  • Adults aged ≥18 years who present with moderate-sized burn injuries [20 - 40% total body surface areas (TBSA)] to the Nepal Cleft and Burn Center within 24 hours of injury.

Exclusion Criteria:

  • Patients with electrical burns, chemical burns, inhalation injury.
  • Patients in overt shock (defined as serum lactate >2.5, or hypotension and altered mental status).
  • Pregnant patients, psychiatrically unstable patients will be excluded.
  • Patients with oropharyngeal defects and/or previously known diagnoses leading to high risk of aspiration, and/or precluding safe nasal-enteric access will be excluded.
  • Patients will history of chronic nausea and/or vomiting, including those with a diagnosis of gastroparesis due to diabetes mellitus will be excluded.
  • Patients with a Baux score of over 100 (age + TBSA), patients with declared palliative intent on admission, and patients for whom clinicians have high level of clinical concern based on clinical judgement will also be excluded.

Sites / Locations

  • Nepal Cleft and Burn Center at Kirtipur Hospital

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Enteral-based Protocolized Resuscitation

Intravenous Fluid Protocolized Resuscitation

Arm Description

Administration of Enteral-based Resuscitation using Oral Rehydration Solution (ORS) either by mouth of via naso-enteric access for moderate sized burn injuries (20-40% TBSA) per resuscitation protocol for burn-injured patients. Resuscitation will be administered in the acute resuscitation phase of burn injury (24-72 hours post injury). Patients will receive supplemental Intravenous Fluid (IV Fluid) resuscitation using Lactated Ringer's solution as needed per protocol.

Administration of Intravenous Fluid using Lactated Ringer's solution per standard of care resuscitation protocol for patients with moderate sized burn injuries (20-40% TBSA).

Outcomes

Primary Outcome Measures

24 Hour Average Urine Output (UOP)
Calculated by totaling all of the recorded urine output (adding up the columns labelled HR 1-2 UO, HR 3-4 UO, etc. until HR 23-24), then dividing by their weight in Kg (column labelled Admission weight) and dividing by 24 hours. The units of this measurement will be mL/kg/hr.
24-hour Resuscitation Volume
Calculated by totaling the total resuscitative fluids administered in first 24 hours of resuscitation, divided by admission weight and % TBSA of burn injury. (cc/kg/% TBSA of burn injury)
Hours From Injury to Resuscitation
Hours calculated from point of injury to starting of resuscitation.

Secondary Outcome Measures

Number of Participants With GI Discomfort
Any "check" for nausea, vomiting, distention, diarrhea
Number of Participants Crossover to IV Due to GI Intolerance
Number of participants crossover to standard of care (IV resuscitation) due to GI intolerance like nausea, vomitting
Number of Participants With Acute Kidney Injury
Measured with any signs of Acute Kidney injury during first 72 hours of resuscitation according to KDIGO definition i.e., increase in serum creatinine by 0.3mg/dL or more within 48 hours or increase in serum creatinine to 1.5 times baseline or more within the last 7 days or urine output less than 0.5 mL/kg/h for 6 hours. AKI on admission was defined as a serum creatinine greater than 1.5 mg/dL with less than 0.5 mL/kg/h of urine output for the first hour. Urine output was measured every 2 hours for the first 24 hours and serum creatinine was measured on admission then 8,16,24,48 and 72 hours from the commencement of the resuscitation.
Participants Death Within 72 Hours of Resuscitation
Secondary resuscitation outcome measured daily within study period i.e. 72 hours of resuscitation as participant death related or associated with the study. Monitored by data safety monitoring board and if proven to be associated with the study considered serious adverse event.
Discharge Outcome
Outcome of hospital stay

Full Information

First Posted
January 20, 2021
Last Updated
October 8, 2023
Sponsor
University of Washington
Collaborators
Fogarty International Center of the National Institute of Health
search

1. Study Identification

Unique Protocol Identification Number
NCT04732624
Brief Title
Enteral Resuscitation Nepal (Pilot Study)
Official Title
Implementation of an Enteral Resuscitation Bundle for Moderate-sized Burn Injuries (20-40% Total Body Surface Area) to Prevent Shock, Coagulopathy, and Kidney and Lung Injury in Nepal
Study Type
Interventional

2. Study Status

Record Verification Date
October 2023
Overall Recruitment Status
Completed
Study Start Date
September 30, 2021 (Actual)
Primary Completion Date
May 31, 2022 (Actual)
Study Completion Date
June 4, 2022 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Washington
Collaborators
Fogarty International Center of the National Institute of Health

4. Oversight

Studies a U.S. FDA-regulated Drug Product
Yes
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
Yes
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Nepal and the South Asian sub-continent carry some of the highest rates of burn injury globally, with an associated high morbidity and mortality. Nepal currently has one major center equipped for burn care, in Kirtipur, Nepal and receives referred patients from around the country. At presentation, most patients with major burns have had minimal to no resuscitation on arrival, often hours to days after the burn injury was sustained. Timely fluid resuscitation, initiated as soon as possible after major burn injury, is the main tenet of acute burn care. Lack of adequate resuscitation in major burn injuries leads to kidney injury, progression of burn injury, sepsis, burn shock, and death. The current standard of care for major burn resuscitation is intravenous fluid resuscitation. In Nepal, however, adequately trained and equipped hospitals for treatment of burn care are not available (for a variety of reasons). Additionally, there is not a systematic emergency medical transport system available for provision of medical care and resuscitation during transport. Enteral-based resuscitation with substances like the WHO Oral Rehydration Solution (ORS) is recommended by burn experts and the professional burn societies when resources and access to intravenous fluid resuscitation are not available in resource-constrained settings such as rural areas, low- and middle-income countries, and military battlefield scenarios. Studies have previously demonstrated the efficacy and safety of enteral-based resuscitation in controlled, high-resource settings, however there have not been real-world effectiveness trials in austere settings. Therefore, the investigators seek to ultimately address the problem of pre-hospital and pre-burn center admission resuscitation by studying the feasibility and effectiveness of enteral resuscitation with Oral Rehydration Solution (ORS) in preventing burn shock. This study examines enteral (oral)-based resuscitation with ORS and IV Fluids versus only IV Fluids for the treatment of major burn injuries. The intervention portion of the study will entail randomization of patients presenting with acute burn injuries of 20-40% total body surface area (TBSA) to an enteral-based resuscitation versus the standard of care IV fluid resuscitation. The intervention will continue through the 24-72 hours of the acute resuscitation period. This is a feasibility study, primarily to develop and establish the research infrastructure and practices at the study site for future pilot study and eventually randomized-controlled trial research on this intervention. The primary outcomes will be measures of feasibility such as the adherence rate to the resuscitation protocols. Further, there will be a qualitative component to the study with focus group interviews of the bedside healthcare providers (doctors and nurses) who are caring for the enrolled patients, in order to understand the challenges and facilitators of enteral resuscitation. Qualitative analysis will be done to understand the major themes of challenges and facilitators to enteral resuscitation.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Burn Body Region Unspecified, Burn Shock
Keywords
Burns, Enteral Resuscitation, Oral Rehydration Solution, Burn Shock, Austere Conditions, Low- and middle-income country

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Model Description
Feasibility study of randomized trial of enteral-based resuscitation (intervention arm) vs. IV fluid resuscitation (standard-of-care arm) for moderate sized burn injuries.
Masking
None (Open Label)
Allocation
Randomized
Enrollment
30 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Enteral-based Protocolized Resuscitation
Arm Type
Experimental
Arm Description
Administration of Enteral-based Resuscitation using Oral Rehydration Solution (ORS) either by mouth of via naso-enteric access for moderate sized burn injuries (20-40% TBSA) per resuscitation protocol for burn-injured patients. Resuscitation will be administered in the acute resuscitation phase of burn injury (24-72 hours post injury). Patients will receive supplemental Intravenous Fluid (IV Fluid) resuscitation using Lactated Ringer's solution as needed per protocol.
Arm Title
Intravenous Fluid Protocolized Resuscitation
Arm Type
Active Comparator
Arm Description
Administration of Intravenous Fluid using Lactated Ringer's solution per standard of care resuscitation protocol for patients with moderate sized burn injuries (20-40% TBSA).
Intervention Type
Drug
Intervention Name(s)
Oral Rehydration Solution
Other Intervention Name(s)
Enteral-based Resuscitation
Intervention Description
Feasibility study of Enteral-based resuscitation with Oral Rehydration Solution (ORS) vs standard-of-care Intravenous Fluid resuscitation for moderate-sized burn injuries in Nepal
Intervention Type
Drug
Intervention Name(s)
Lactated Ringer
Other Intervention Name(s)
Intravenous Fluid Resuscitation
Intervention Description
Standard-of-care Intravenous Fluid resuscitation
Primary Outcome Measure Information:
Title
24 Hour Average Urine Output (UOP)
Description
Calculated by totaling all of the recorded urine output (adding up the columns labelled HR 1-2 UO, HR 3-4 UO, etc. until HR 23-24), then dividing by their weight in Kg (column labelled Admission weight) and dividing by 24 hours. The units of this measurement will be mL/kg/hr.
Time Frame
24 hours
Title
24-hour Resuscitation Volume
Description
Calculated by totaling the total resuscitative fluids administered in first 24 hours of resuscitation, divided by admission weight and % TBSA of burn injury. (cc/kg/% TBSA of burn injury)
Time Frame
24 hours
Title
Hours From Injury to Resuscitation
Description
Hours calculated from point of injury to starting of resuscitation.
Time Frame
Point measurement (Once at the start of resuscitation)
Secondary Outcome Measure Information:
Title
Number of Participants With GI Discomfort
Description
Any "check" for nausea, vomiting, distention, diarrhea
Time Frame
24 hours
Title
Number of Participants Crossover to IV Due to GI Intolerance
Description
Number of participants crossover to standard of care (IV resuscitation) due to GI intolerance like nausea, vomitting
Time Frame
24hours
Title
Number of Participants With Acute Kidney Injury
Description
Measured with any signs of Acute Kidney injury during first 72 hours of resuscitation according to KDIGO definition i.e., increase in serum creatinine by 0.3mg/dL or more within 48 hours or increase in serum creatinine to 1.5 times baseline or more within the last 7 days or urine output less than 0.5 mL/kg/h for 6 hours. AKI on admission was defined as a serum creatinine greater than 1.5 mg/dL with less than 0.5 mL/kg/h of urine output for the first hour. Urine output was measured every 2 hours for the first 24 hours and serum creatinine was measured on admission then 8,16,24,48 and 72 hours from the commencement of the resuscitation.
Time Frame
72 hours
Title
Participants Death Within 72 Hours of Resuscitation
Description
Secondary resuscitation outcome measured daily within study period i.e. 72 hours of resuscitation as participant death related or associated with the study. Monitored by data safety monitoring board and if proven to be associated with the study considered serious adverse event.
Time Frame
72 hours
Title
Discharge Outcome
Description
Outcome of hospital stay
Time Frame
Measured over complete course of hospitalization until discharge or death, assessed every 24 hours after enrollment in the study. Maximum timeframe 6 months.

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: All genders Adults aged ≥18 years who present with moderate-sized burn injuries [20 - 40% total body surface areas (TBSA)] to the Nepal Cleft and Burn Center within 24 hours of injury. Exclusion Criteria: Patients with electrical burns, chemical burns, inhalation injury. Patients in overt shock (defined as serum lactate >2.5, or hypotension and altered mental status). Pregnant patients, psychiatrically unstable patients will be excluded. Patients with oropharyngeal defects and/or previously known diagnoses leading to high risk of aspiration, and/or precluding safe nasal-enteric access will be excluded. Patients will history of chronic nausea and/or vomiting, including those with a diagnosis of gastroparesis due to diabetes mellitus will be excluded. Patients with a Baux score of over 100 (age + TBSA), patients with declared palliative intent on admission, and patients for whom clinicians have high level of clinical concern based on clinical judgement will also be excluded.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Kajal Mehta, MD, MPH
Organizational Affiliation
University of Washington
Official's Role
Principal Investigator
Facility Information:
Facility Name
Nepal Cleft and Burn Center at Kirtipur Hospital
City
Kirtipur
State/Province
Bagmati
Country
Nepal

12. IPD Sharing Statement

Learn more about this trial

Enteral Resuscitation Nepal (Pilot Study)

We'll reach out to this number within 24 hrs